Dana-Farber Cancer Institute Nurses Have Voted to Ratify New MNA Contract | Featuring Significant Investment in Nursing and Patient Care

The almost 800 registered nurses and nurse practitioners at Dana-Farber Cancer Institute (DFCI), represented by the Massachusetts Nurses Association (MNA), have voted overwhelmingly to ratify a new contract agreement that provides market-leading investments in nurses, enabling DFCI to retain experienced nurses and recruit the nurses necessary to delivering exceptional cancer care and conducting innovative research.

“We are incredibly proud of the care we provide Dana-Farber patients and the unity our nurses have shown in securing the resources we need to continue delivering exceptional care,” said Stephen Laughlin, RN, MNA Chair at DFCI. “The new Dana-Farber nurse contract will help us maintain our top of the market status and allow the institute to recruit and retain top nurses who provide cutting edge cancer treatments.”

DFCI nurses voted by mail, with the vote count occurring on July 18. Their new two-year contract covers January 1, 2024, to December 31, 2025. The ratification comes as Brigham and Women’s Hospital and Brigham and Women’s Faulkner Hospital nurses are on the verge of strike authorization votes. Nurses at both hospitals are seeking strong investments by MGB in their RN workforces to overcome unsafe staffing and patient care conditions.

DFCI RN Contract Highlights

  • Wage Increases: To keep up with a competitive nurse market and complex patient care challenges, DFCI agreed to provide a 9% raise to all nurses in the first year of the contract, including retroactive pay. Nurses will receive a 3% increase in year two with a new partial top step created that is 3% above the current top wage scale step.
  • Attracting Newer Nurses: DFCI agreed to drop the current bottom wage scale step of the contract, raising the rate for newer nurses and making the institute more competitive in this recruitment area.
  • On-Call Improvement: The on-call pay rate will increase to the state’s minimum wage (currently $15/hour). Historically, at DFCI and elsewhere on-call hourly rates have been much lower than the minimum wage and regular pay, burdening nurses who face demanding on-call responsibilities amid an increasing need for expert nursing care.
  • Grievance Enhancement: Nurses will now be able to file collective grievances when confronting violations of their contract. Previously, only individual grievances were allowed. DFCI nurses will be able to join together while seeking resolution of violations in which they are similarly affected.
  • Seniority Scheduling: DFCI nurses negotiated scheduling by seniority into their contract to ensure a fair application of scheduling by management across hospital units.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.